ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.9517 ↑ 0.43%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -4.05% 0.43% 1.07% 0.13% -0.31% -0.5% 22.83%---

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.83% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.17%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology10.60%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology8.38%
Apollo Hospitals Enterprise LimitedHealthcare Services5.96%
Max Healthcare Institute LimitedHealthcare Services5.89%
Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology4.53%
Cohance Lifesciences LimitedPharmaceuticals & Biotechnology4.31%
Fortis Healthcare LimitedHealthcare Services3.87%
Aurobindo Pharma LimitedPharmaceuticals & Biotechnology3.43%
Aster DM Healthcare LimitedHealthcare Services3.30%
Lupin LimitedPharmaceuticals & Biotechnology3.01%
Mankind Pharma LimitedPharmaceuticals & Biotechnology2.97%
Alkem Laboratories LimitedPharmaceuticals & Biotechnology2.91%
Wockhardt LimitedPharmaceuticals & Biotechnology2.49%
Neuland Laboratories LimitedPharmaceuticals & Biotechnology2.36%
Abbott India LimitedPharmaceuticals & Biotechnology2.34%
Cipla LimitedPharmaceuticals & Biotechnology2.33%
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology2.02%
Healthcare Global Enterprises LimitedHealthcare Services1.87%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology1.65%
Sumitomo Chemical India LimitedFertilizers & Agrochemicals1.55%
Vijaya Diagnostic Centre LimitedHealthcare Services1.52%
FDC LimitedPharmaceuticals & Biotechnology1.43%
Rainbow Childrens Medicare LimitedHealthcare Services1.33%
Laurus Labs LimitedPharmaceuticals & Biotechnology1.33%
IPCA Laboratories LimitedPharmaceuticals & Biotechnology1.27%
SBI Life Insurance Company LimitedInsurance1.24%
Orchid Pharma LimitedPharmaceuticals & Biotechnology1.17%
Standard Glass Lining Technology LtdIndustrial Manufacturing1.05%
Onesource Specialty Pharma LimitedPharmaceuticals & Biotechnology1.04%
Sagility India LimitedIT - Services1.00%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.97%
Supriya Lifescience LimitedPharmaceuticals & Biotechnology0.96%
SRF LimitedChemicals & Petrochemicals0.94%
Shilpa Medicare LimitedPharmaceuticals & Biotechnology0.92%
Caplin Point Laboratories LimitedPharmaceuticals & Biotechnology0.91%
Linde India LimitedChemicals & Petrochemicals0.88%
Navin Fluorine International LimitedChemicals & Petrochemicals0.82%
Glenmark Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.78%
UPL LimitedFertilizers & Agrochemicals0.73%
Biocon LimitedPharmaceuticals & Biotechnology0.68%
Zydus Lifesciences LimitedPharmaceuticals & Biotechnology0.62%
Syngene International LimitedHealthcare Services0.47%

Debt

NameRatingWeight %
Portfolio data is as on date 31 August, 2025

NAV (Net asset value) history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history

DateNAV
20 October, 202517.9517
17 October, 202517.8741
16 October, 202517.7908
15 October, 202517.6808
14 October, 202517.6586
13 October, 202517.7620
10 October, 202517.7775
9 October, 202517.5972
8 October, 202517.4341
7 October, 202517.4689
6 October, 202517.4303
3 October, 202517.2630
1 October, 202517.2759
30 September, 202517.0899
29 September, 202517.1077
26 September, 202517.0324
25 September, 202517.4458
24 September, 202517.5493
23 September, 202517.6683
22 September, 202517.7632
19 September, 202517.9287
18 September, 202517.8406
17 September, 202517.7592
16 September, 202517.7713
15 September, 202517.7295
12 September, 202517.7843
11 September, 202517.7868
10 September, 202517.7262
9 September, 202517.6307
8 September, 202517.5608

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 17.9517 as on 20 October, 2025.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -4.05% as on 20 October, 2025.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -0.5% as on 20 October, 2025.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 22.83% as on 20 October, 2025.